ArticleJournal of translational medicine2025
Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway.
Zhixiong Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleJournal of translational medicine2025
Zhixiong Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.